AH

Alan H. Auerbach

North America, California, United States, Los Angeles

Description

Auerbach is the Founder, President, and CEO of Puma Biotechnology, a company dedicated to in-licensing and developing drugs for the treatmen...

Investor Profile

Alan H. Auerbach has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Medical, Therapeutics.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alan H. Auerbach frequently co-invest with?

Athyrium Capital Management LP
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Alan H. Auerbach?

Puma Biotechnology

Los Angeles, California, United States

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

BiotechnologyMedicalTherapeutics
Post Ipo EquityMar 10, 2022
Amount Raised: $10,000,000